This year, the FDA approved three drugs meant to prevent migraines and those, along with less expensive and less invasive techniques to stimulate the body’s response to pain through neurostimulation, are giving optimism to headache specialists and their patients after years of little progress.
from Kaiser Health News https://ift.tt/2zJIgSb
December 04, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
How a Former Catholic Priest Is Navigating a California Medicaid Plan Through Big Changes ORANGE, Calif. — For Michael Hunn, the path from priesthood to health care was seamless. Hunn, a native of St. Louis, counseled hospitalized patients as a Catholic priest in the 1980s before leaving the clergy and shifting to… Read More
Who Doesn’t Text in 2022? Most State Medicaid ProgramsWest Virginia will use the U.S. Postal Service and an online account this summer to connect with Medicaid enrollees about the expected end of the covid public health emergency, which will put many recipients at risk of losing… Read More
A Year In, Montana’s Rolled-Back Public Health Powers Leave Some Areas in LimboA year after a new Montana law stripped local health boards of their rulemaking authority, confusion and power struggles are creating a patchwork oversight system that may change how public health is administered long after t… Read More
A Travel Nurse Leaves Fears of Hospital Drug Tampering Across Three StatesHealth officials in at least three states are investigating a travel nurse suspected of tampering with and potentially contaminating vials and syringes of opioid painkillers in two hospitals, then returning the vials to medic… Read More
Persistent Problem: High C-Section Rates Plague the SouthAll along, Julia Maeda knew she wanted to have her baby naturally. For her, that meant in a hospital, vaginally, without an epidural for pain relief. This was her first pregnancy. And although she is a nurse, she was working … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment